Coya Therapeutics (COYA) EPS (Basic) Growth (1y) (2023 - 2026)
Coya Therapeutics (COYA) EPS (Basic) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | 88.81% |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 1,201.33% |
| 10 | Coya Therapeutics | 98.05 Mn | 47.33 Mn | - | 27.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.17% |
| Dec 31, 2025 | 36.08% |
| Sep 30, 2025 | 47.13% |
| Jun 30, 2025 | -87.97% |
| Mar 31, 2025 | -25.06% |
| Dec 31, 2024 | -113.74% |
| Sep 30, 2024 | -20.66% |
| Jun 30, 2024 | 56.55% |
| Mar 31, 2024 | 14.66% |
| Dec 31, 2023 | 67.67% |
| Sep 30, 2023 | 55.68% |
| Jun 30, 2023 | 66.46% |
| Mar 31, 2023 | 37.63% |